Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Tangoe Prices Registered Public Offering Of 8 Mln Shares At $18.50/Shr

RELATED NEWS
Trade TNGO now with 

Tangoe, Inc. (TNGO: Quote) said it priced registered public offering of an aggregate of 8 million shares of common stock at a price to the public of $18.50 per share. Of the shares in the offering, 2.2 million shares are being offered by Tangoe, and 5.8 million shares are being offered by selling stockholders.

In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to 1.2 million additional shares at the public offering price.

Tangoe said it will not receive any proceeds from the sale of shares by the selling stockholders.

Click here to receive FREE breaking news email alerts for TANGOE INC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Denis Mukwege, a doctor from the Democratic Republic of Congo, has won this year's Sakharov Prize for Freedom of Thought for helping thousands of gang rape victims in the country. The award was instituted by the European Parliament, and the laureate for 2014 was selected by EP President Martin Schulz and the political group leaders. Announcing Europe's top human rights prize Tuesday, Schulz said Stocks moved sharply higher over the course of the trading day on Tuesday, extending the recovery from the sell-off seen in recent weeks. The Nasdaq and the S&P 500 closed higher for the fourth consecutive session but remain well off their mid-September highs. Despite indications that the spread of Ebola inside the U.S. has been contained, the results of a new Gallup poll show the deadly disease had made its debut on a list of the top 10 most important problems facing the country.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.